Evidence map›Paper›PMID 29551766›Full record

ArticleOncogene2018

Thyroid transcription factor 1 enhances cellular statin sensitivity via perturbing cholesterol metabolism.

Shao-Chiang Lai, Cody A Phelps, Aleena M Short, Sucharita M Dutta, David Mu

Open access · greenAbstract read
In one paragraph

Article in Oncogene, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Identification of potential bioactive compounds ofBiochemistry and biophysics reports · 2023
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shao-Chiang LaiLeroy T. Canoles Jr. Cancer Research Center, Eastern Virginia Medical School, Norfolk, VA, 23501, USA.
Cody A PhelpsLeroy T. Canoles Jr. Cancer Research Center, Eastern Virginia Medical School, Norfolk, VA, 23501, USA.
Aleena M ShortBiotechnology Master's Program, Eastern Virginia Medical School, Norfolk, VA, 23501, USA.
Sucharita M DuttaLeroy T. Canoles Jr. Cancer Research Center, Eastern Virginia Medical School, Norfolk, VA, 23501, USA.
David MuLeroy T. Canoles Jr. Cancer Research Center, Eastern Virginia Medical School, Norfolk, VA, 23501, USA. mud@evms.edu.ORCID http://orcid.org/0000-0002-7762-0182
Eastern Virginia Medical School · USBeth Israel Deaconess Medical Center · US

Funding

Modifier of Cancer Sensitivity to StatinsR21CA198327 · NCI · EASTERN VIRGINIA MEDICAL SCHOOL · PI MU, DAVID · 2016 to 2017
$351k
NCI NIH HHS R21 CA198327
6 · The paper itself

Abstract

We have discovered an unexpected connection between a critical lung development and cancer gene termed thyroid transcription factor 1 (TTF-1 also known as NKX2-1) and cholesterol metabolism. Our published work implicates that TTF-1 positively regulates miR-33a which is known to repress ATP-binding cassette transporter 1 (ABCA1) and thus its cholesterol efflux activity. We set out to demonstrate that a higher TTF-1 expression would presumably inhibit cholesterol efflux and consequently raise intracellular cholesterol level. Surprisingly, raising TTF-1 expression actually lowers intracellular cholesterol level, which, we believe, is attributed to a direct transactivation of ABCA1 by TTF-1. Subsequently, we show that lung cancer cells primed with a TTF-1-driven decrease of cholesterol were more vulnerable to simvastatin, a frequently prescribed cholesterol biosynthesis inhibitor. In view of the fact that pathologists routinely interrogate human lung cancers for TTF-1 immunopositivity to guide diagnosis and the prevalent use of statins, TTF-1 should be further investigated as a putative biomarker of lung cancer vulnerability to statins.

Indexed as

A549 CellsAnimalsATP Binding Cassette Transporter 1Cell LineCell Line, TumorCholesterolDNA-Binding ProteinsGene Expression Regulation, NeoplasticHumansHydroxymethylglutaryl-CoA Reductase InhibitorsLung NeoplasmsMiceMicroRNAsSimvastatinThyroid Nuclear Factor 1Transcription FactorsABCA1 protein, humanATP Binding Cassette Transporter 1CholesterolDNA-Binding ProteinsHydroxymethylglutaryl-CoA Reductase InhibitorsMicroRNAsMIRN33a microRNA, humanNKX2-1 protein, humanSimvastatinThyroid Nuclear Factor 1Transcription Factors

Identifiers

PMID29551766
PMCPMC6003839
OpenAlexW2791237040

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.